Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK437M in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
Agios Pharmaceuticals AGIO:US USD -90613000 119.29M
Almirall SA ALM:SM EUR -946000 48.76M
Amgen AMGN:US USD 2.03B 196M
Artemis Alpha ATS:LN GBP -16578000 10.12M
AstraZeneca AZN:LN USD 2.55B 1.46B
Bayer BAYN:GR EUR 2.97B 1.54B
BioMarin Pharmaceutical BMRN:US USD 59.35M 83.85M
Bluebird Bio BLUE:US USD 8.44M 17M
Demant A/s WDH:DC DKK 1.62B 31M
Exelixis EXEL:US USD 28.83M 76.91M
Fresenius Medical Care FME:GR EUR 261M 90.93M
Galapagos GLPG:NA EUR 21.97M 154.43M
Genmab GEN:DC DKK 437M 2.23B
GlaxoSmithKline GSK:LN GBP 2.08B 215M
GN Store Nord GN:DC DKK 70M 368M
Hikma Pharmaceutical HIK:LN USD 60M 189M
Immunogen IMGN:US USD -42393000 17.17M
Insmed INSM:US USD -148158000 3.32M
Lonza Group LONN:SW CHF 896M 251M
Novartis NOVN:VX USD 2.86B 907M
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Roche Holding ROG:VX CHF 5.93B 5.62B
Seattle Genetics SGEN:US USD -184513000 30.51M